OTHER (INCOME)/EXPENSE

3 Months Ended

Mar. 31, 2017

Other Nonoperating Income (Expense) [Abstract]

Other (Income)/Expense [Text Block]

OTHER (INCOME)/EXPENSE

	Three Months Ended March 31,
Dollars in Millions	2017			2016
Interest expense	$	45		$	43
Investment income	(33		)	(24		)
Provision for restructuring	164			4
Litigation and other settlements(a)	(484		)	43
Equity in net income of affiliates	(18		)	(26		)
Divestiture gains	(127		)	(270		)
Royalties and licensing income	(199		)	(254		)
Transition and other service fees	(7		)	(53		)
Pension charges	33			22
Intangible asset impairments	—			15
Other	(21		)	(20		)
Other (income)/expense	$	(647	)	$	(520	)

(a) Includes BMS's share of a patent-infringement litigation settlement of $481 million related to Merck's PD-1 antibody Keytruda*.